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ARTICLE
FraC nanopores with adjustable diameter identify
the mass of opposite-charge peptides with 44
dalton resolution
Gang Huang1, Arnout Voet2 & Giovanni Maglia1
A high throughput single-molecule method for identifying peptides and sequencing proteins
based on nanopores could reduce costs and increase speeds of sequencing, allow the fab-
rication of portable home-diagnostic devices, and permit the characterization of low abun-
dance proteins and heterogeneity in post-translational modiﬁcations. Here we engineer the
size of Fragaceatoxin C (FraC) biological nanopore to allow the analysis of a wide range of
peptide lengths. Ionic blockades through engineered nanopores distinguish a variety of
peptides, including two peptides differing only by the substitution of alanine with glutamate.
We also ﬁnd that at pH 3.8 the depth of the peptide current blockades scales with the mass
of the peptides irrespectively of the chemical composition of the analyte. Hence, this work
shows that FraC nanopores allow direct readout of the mass of single peptide in solution,
which is a crucial step towards the developing of a real-time and single-molecule protein
sequencing device.
https://doi.org/10.1038/s41467-019-08761-6 OPEN
1 Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG Groningen, The Netherlands. 2 Laboratory of Biomolecular
Modelling and Design, Department of Chemistry, University of Leuven, Celestijnenlaan 200G, 3001 Heverlee, Belgium. Correspondence and requests for
materials should be addressed to G.M. (email: g.maglia@rug.nl)









Proteins regulate nearly all life processes. Currently, massspectrometry is the method of choice for protein analysis,sequencing, and proteome characterization. In a typical
experiment in bottom-up proteomics, proteins are extracted and
proteolytically digested into peptides and separated by liquid
chromatography. Peptide spectra are then collected using tandem
mass spectrometry, within a cycle time of about 1 s1. Using this
method, most of the proteins that have been expressed in an
organism can be identiﬁed and quantiﬁed. However, proteins in
biological samples are extremely heterogeneous, spanning several
orders of magnitude in abundance. In addition, most eukaryote
proteins contain a variegated and dynamic range of post-
translational modiﬁcations (PTMs). Due to the fast amount of
conceivable combinations, the identiﬁcation and sequencing of
proteins in such heterogeneous mixtures is challenging for con-
ventional mass spectrometry2.
A high-throughput single-molecule technique could address
these limitations. Although no single-molecule protein sequencer
exists today, a few approaches have been proposed, mainly aimed
at protein identiﬁcation. For instance, it has been shown that if
only cysteine and lysine residues are read in sequence, most of
human proteins can be identiﬁed3. In a recent proof-of-concept
experiment4, peptides with cysteine and a lysine residues were
labeled with a ﬂuorescence acceptor, whereas a ClpXP unfoldase/
protease was labeled with a ﬂuorescence donor. Then, single-
molecule Förster resonance energy transfer was used to monitor
the passage of the acceptor dyes near the donor dye as the line-
arized polypeptide was processively transported through the
ClpXP chamber. In another recent method, millions of peptides
with ﬂuorescently labeled cysteine5–7, lysine, or phosphoserine
residues were immobilized on a glass coverslip. Total internal
reﬂection ﬂuorescence microscopy was then used to monitor each
molecule’s ﬂuorescence following consecutive cycles of N-
terminal amino acid removal using Edman degradation chem-
istry. The authors identiﬁed a variety of peptides and achieved
single-molecule positional readout of the phosphorylated sites.
Nanopores might also be used for single-molecule protein
analysis and sequencing. Stein and co-workers proposed to couple
a nanopore to a mass spectrometer. The nanopore would linearize
individual proteins, whereas the mass spectrometer would be
used to identify peptides as they are sequentially cleaved8. In a
more conventional nanopore approach, an external potential is
applied across the nanopore and the resulting ionic current is
used to recognize proteins or peptides traversing the nanopore. In
an early experiment, inspired by DNA nanopore sequencing, a
ClpXP enzyme complex was used to force the unfolding of a
protein through a biological nanopore9. An independent study
showed that nanopore currents are capable of recognizing mod-
iﬁcations in individual amino acid within a linearized polypeptide
strand10. However, despite these encouraging results enzymes
that process proteins or polypeptides amino-acid-by-amino-acid
are yet to be discovered.
In an alternative approach, a protease is placed atop of a
nanopore to fragment a protein. Then the mass of individual
peptides is identiﬁed by nanopore currents. This method would
be similar to conventional protein sequencing using tandem mass
spectrometry, with the additional advantage of being low-cost,
portable, and single molecule. For this approach to be feasible,
however, the signal rising from the peptide blockade must be
directly correlated to the mass of the peptide. Previous work with
PEG molecules11–17, oligosaccharides18, and homopolymeric
peptides19–21 revealed that there might be a direct correlation
between the depth of the current blockade and the molecular
weight of polymers, providing the charge composition of the
analyte is uniform22. In such circumstances, it has been shown
that nanopores can resolve the signal of poly-arginine peptides
from 10 to 5 amino acids, hence distinguishing peptides differing
by one arginine in length (174 Da)19. Peptides in a biological
sample, however, have a heterogenous chemical composition.
Work with DNA23,24 and amino-acid enantiomers25 revealed that
the chemical identity of molecules and the charge inside the
nanopore26 have an unpredictable effect on the ionic current. On
the other hand, additional work with peptides showed that the
correlation between mass and ionic signal is retained with
peptides27,28, providing they are either neutral or uniformly
charged. Nonetheless, peptides with an overall charge that is
opposite to the applied bias have not been systematically studied,
most likely because they are not efﬁciently captured and analyzed
at such potentials29–32. Finally, the diameter and geometry of
biological nanopores cannot be easily adapted to study the array
of sizes, shapes, and chemical composition of polypeptides in
solution.
Recently, we have shown that octameric fragaceatoxin C (FraC,
Fig. 1a) nanopores33 from the sea anemone Actinia fragacea can
be used to study DNA34, proteins, and peptides35. The trans-
membrane region of FraC is unique compared with other
nanopores used in biopolymer analysis as it is formed by α-
helices that describe a sharp and narrow constriction at the trans
exit of the nanopore. We showed that an electroosmotic ﬂow
across the nanopore can be engineered to capture polypeptides at
a ﬁxed potential despite their charge composition35. However,
peptides smaller than 1.6 kDa in size translocated too fast across
the nanopore to be sampled, indicating that nanopores with a
smaller diameter should be used to detect peptides with lower
molecular weight. In this work, we show that the diameter of
FraC nanopores can be tuned, permitting the identiﬁcation of a
large range of peptides sizes. Using engineered nanopores, we also
show that peptides differing by the substitution of one-amino acid
(44 Da) can be identiﬁed. At selected pH conditions, the nano-
pore signal directly correlates to the mass of the peptide,
including peptides with high content of acidic residues (i.e.,
negatively charged peptides at physiological pH). Therefore, this
nanopore approach can be used to identify the mass of individual
peptides in solution and, providing a protease is attached
immediately above the nanopore, might allow the sequencing of
proteins in real-time.
Results
Engineering the size of FraC nanopores. One of the main
challenges in biological nanopores analysis is to obtain nanopores
with different size and shape. Most biological nanopores are
formed by multiple repeats of individual monomers. Hence,
different nanopore sizes might be obtained by engineering the
protein oligomeric composition36. We noticed that at pH 7.5 a
small fraction of wild-type FraC (Wt-FraC) nanopores showed a
lower conductance (1.26 ± 0.08 nS, −50 mV, type II Wt-FraC)
compared with the dominant fraction (2.26 ± 0.08 nS, −50 mV,
type I Wt-FraC), suggesting that FraC might be able to sponta-
neously assemble into nanopores with a smaller size. At pH 4.5,
type I and type II FraC nanopores were also observed, however, a
smaller nanopore conductance was identiﬁed alongside (0.42 ±
0.03 nS, type III Wt-FraC, −50 mV, Fig. 1b). Occasionally,
nanopores with a yet smaller conductance were observed, how-
ever, their appearance was too rare for meaningful characteriza-
tion. We noticed that the reconstitution of lower conductance
nanopores depended on several puriﬁcation conditions (Supple-
mentary Figure 1 and 2). In particular, the occurrence of type II
and type III nanopores increased when the oligomers were stored
in solution for several weeks or when the concentration of
monomeric Wt-FraC was reduced during oligomerization (Sup-
plementary Figure 1 and 2). In an effort to enrich type II and type
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III FraC nanopores, we weakened the interaction between the
nanopore and the lipid interface by substituting W112 and W116
at the lipid interface of FraC (Fig. 1a) with serine. We reasoned
that a lower concentration of monomers, during oligomerization,
would increase the population of lower molecular mass oligo-
mers. Rewardingly, we found that at both pH 7.5 and pH 4.5 the
proportion of type II and type III FraC nanopores increased
dramatically. For example, W112S-W116S-FraC formed 60% of
type II pore at pH 7.5, and 40% of type III pore at pH 4.5 (Fig. 1b,
Supplementary Figure 3). The different nanopore types could also
be separated by Ni-NTA afﬁnity chromatography using an imi-
dazole gradient (Supplementary Figure 2e-f). Finally, at pH 7.5,
type II and type III FraC nanopores could also be obtained by
replacing aspartic acid 109 (Supplementary Note 1, Supplemen-
tary Figure 2g-h, 3e-f) at the lipid interface with serine. Impor-
tantly, the reconstituted type II and type III nanopores did not
show any particular gating (spontaneous opening and closing) or
bilayer instability (e.g., the detachment of the nanopores from the
lipid bilayer was never observed).
Among FraC nanopores of the same type, the lipid interface
modiﬁcations brought by W112S and W116S substitutions did
not alter the conductance and ion selectivity of the nanopores
(Fig. 1c, Supplementary Figure 3 and 4, Supplementary Table 1),
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Fig. 1 Preparation and characterization of type I, type II, and type III fragaceatoxin C (FraC) nanopores. a Cut through of a surface representation of wild-
type FraC (Wt-FraC) oligomer (PDB: 4TSY33) colored according to the vacuum electrostatic potential as calculated by PyMOL. One protomer is shown as
a carton presentation with tryptophans 112 and 116 displayed as spheres. b Percentage of the distribution of type I, type II, and type III for Wt-FraC, W112S-
FraC, W116S-FraC, and W112S-W116S-FraC at pH 7.5 and 4.5. c IV curves of type II nanopores formed by Wt-FraC, W116S-FraC, and W112S-W116S-FraC
at pH 4.5. d Single nanopore conductance of W116S-FraC in 1M KCl at pH 4.5 and –50mV. e Typical current traces for the three nanopore types of W116S-
FraC in 1 M KCl at pH 4.5 under –50mV applied potential. f Reversal potentials measured under asymmetric condition of KCl (1960mM cis, 467mM trans)
at pH 4.5 for the three W116S-FraC nanopore types. The ion selectivity was calculated using the Goldman–Hodgkin–Katz equation (Eq. 1)52. g Molecular
models of the three type FraC nanopores constructed from the FraC crystals structure using the symmetrical docking function of Rosetta. The diameters
were measured from the distance between opposite side chains of D10 and include the van der Waals radii of the atoms. The electrophysiology recordings
were performed with a 10 kHz sampling and a 2 kHz Bessel ﬁlter. The error bars and color shadow in the I–V curves are standard deviations from at least
three repeats
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by the surface modiﬁcations. When characterized in lipid bilayers,
type I, type II, and type III nanopores showed a well-deﬁned
single conductance distribution, a steady open pore current
(Figs. 1d, e) and comparable power spectra (Supplementary
Figure 5). Interestingly, the nanopore types with a reduced
conductance also showed an increased cation selectivity (2.0±0.1,
2.5±0.2, and 4.2±0.2 for type I, type II, type III W116S-FraC
nanopores, respectively, at pH 4.5, Fig. 1f, Supplementary
Table 1). The increased ion selectivity most likely reﬂects a
larger overlap of the electrical double layer in the nanopores with
a narrower constriction. These and several addition lines of
evidence (Supplementary note 1, Supplementary Figure 6)
strongly suggest that the three types of FraC nanopores represent
nanopores with different protomeric compositions. Molecular
modeling allowed predicting the diameter of type II (1.1 nm) and
type III (0.84 nm) nanopores (Fig. 1g). These values corresponded
well to the diameters estimated from their conductivity values
(1.17 ± 0.04 and 0.71 ± 0.01 for type II and type III, Supplemen-
tary Figure 3). Notably, type III FraC, having a sub-nanometer
constriction, is the biological nanopore with the smallest inner
diameter known to date.
Identiﬁcation of single amino-acid substitutions with type II
FraC nanopores. Type II FraC nanopores were used to sample a
series of angiotensin peptides (Figs. 2–3, Table 1, Supplementary
Figure 7), which regulate blood pressure and ﬂuid balance. The
peptides were added to the cis side of type II W116S-FraC
nanopores and the magnitude of the ionic current associated with
a peptide blockade (IB) was measured. The pH of the solution was
set to 4.5, because at higher pH the capture of some peptides was
either not observed or greatly reduced35. To characterize the
peptide blockade, we used the percentage of excluded currents
(Iex%), deﬁned as [(IO – IB)/IO] × 100, where IO represents the
open pore current. Iex%, which relates to the ionic current that is
lost during the transit of the peptide across the nanopore, and is
expected to be proportional to the volume inside the nanopore
excluded by the peptide. Angiotensin I (DRVYIHPFHL, 1296.5
Da), showed the deepest blockade (Iex%= 91.2 ± 0.2) and angio-
tensin IV (VYIHPF, 774.9 Da) the shallowest blockade (Iex%=
61.1 ± 4.0). The percent of excluded current of angiotensin II
(DRVYIHPF, 1046.2 Da, Iex%= 82.1 ± 1.3) and angiotensin III
(RVYIHPF, 931.1 Da, Iex%= 77.9±0.5) fell at intermediate values.
When the four peptides were tested simultaneously, individual
peptides could be discriminated (Fig. 2f).
The resolution limit of the nanopore sensor was challenged by
sampling mixtures of angiotensin II and angiotensin A, which
have an identical composition with the exception of the initial
amino acid that is aspartate in angiotensin II and alanine in
angiotensin A. These two peptides, differing by 44 Da, appeared
as distinctive peaks in Iex% plots (Fig. 3). Smaller peptide
differences, e.g., the 34 Da difference between phenylalanine and
isoleucine in angiotensin III and Ile7 angiotensin III, were
observed but not easily detected (Supplementary Figure 8),
placing the resolution of our system at ~ 40 Da. It should be
noticed that a more complex classiﬁcation of peptides has been
demonstrated elsewhere37–39, and would likely improve the
sensitivity of discrimination. Smaller peptides such as angiotensin
II 4–8 (YIHPF, 675.8 Da), endomorphin I (YPWF, 610.7 Da), or
leucine enkephalin (YGGFL, 555.6 Da) translocated too quickly
across type II W116S-FraC nanopores to be sampled, but they
could be measured using type III W112S-W116S-FraC nanopores
(Table 1, Supplementary Note 2, Supplementary Figure 9-11).
a Angiotensin I (Ang I):     D R V Y I H P F H L      
Angiotensin II (Ang II):   D R V Y I H P F           
Angiotensin III (Ang III):     R V Y I H P F  
Angiotensin IV (Ang IV):        V Y I H P F
0.5 ms























































































Ang I (1296.5 Da, Iex% = 91.2 ± 0.1) Ang II (1046.2 Da, Iex% = 82.1 ± 1.3)
Ang III (931.1 Da, Iex% = 77.9 ± 0.5) Ang IV (774.9 Da, Iex% = 61.1 ± 3.9) Mixture
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Fig. 2 Discrimination of angiotensin peptides using type II W116S-fragaceatoxin C (FraC) nanopores at pH 4.5. a Peptide sequences of angiotensin I (Ang
I), angiotensin II (Ang II), angiotensin III (Ang III), and angiotensin IV (Ang IV) and typical blockades provoked by the four angiotensin peptides measured
at −30mV. b–e Color density plot of the Iex% versus the standard deviation of the current amplitude for angiotensin I, II, III, and IV, respectively.
f Discrimination of four angiotensin peptides in a mixture. Peptides were added into the cis chamber and measured at −30mV. Standard deviations were
calculated from at least three independent repeats. Color density plots were created using Origin
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A nanopore mass spectrometer for peptides. Although the
ability of nanopores to distinguish between known analytes is
useful, a more powerful application would be the identiﬁcation of
peptide masses directly from ionic current blockades without
holding prior knowledge of the analyte identity. In nanopores,
ionic current blockades are expected to be directly proportional to
the volume excluded by the analyte inside the nanopore40. Hence,
the current blockade of a peptides should reveal the volume of the
peptide, which might approximate to its mass by the relation:
volume (nm3)= 1.212 × 10−3 (nm3/Da) ×MW (Da)41,42. In the
effort to assess FraC nanopores as a peptide mass identiﬁer, we
tested additional peptides at pH 4.5 in 1M KCl solutions using
type I, type II, and type III FraC nanopores (Figs. 4a–c, Table 1,
Supplementary Figure 7, 10, 12). We found that for most peptides
there was a direct correlation between the excluded current and
the volume/mass of the peptide. Although linear regression
ﬁtted the data well, if the expected values for an empty nanopore
were to be included (i.e., Iex% is zero when no peptide is inside the
nanopore), quadratic functions showed best ﬁts for the data
collected with type I and type II nanopores (Figs. a, b). By con-
trast, linear regressions could be used for the data measured with
type III FraC nanopores (Fig. 4c). Interestingly, the extrapolated
volumes for a fully occupied nanopore (3.5 nm3, 2.0 nm3, and
0.96 nm3 for type I, type II, and type III FraC, respectively), were
similar to the volumes comprised between D10 and D17 residues
of FraC (3.6 nm3, 1.8 nm3, and 1.0 nm3, respectively, Fig. 4),
suggesting that the constriction (D10) and the amino acid one
turn of the helix above it (D17) most likely deﬁne the sensing
region within the nanopore.
Although the Iex% of most peptides ﬁtted well to the empirical
quadratic functions, two notable exceptions were c-Myc 410–419
(1203.3 Da) and neuropeptide-like protein 3 (NLP-3) (66–75,
1099.2 Da). These peptides were intentionally selected because
they included several acidic residues (Table 1). c-Myc 410-419
and NPL-3 (added in cis) could be readily captured at negative
applied potentials (trans), indicating that the cis to trans
electroosmotic ﬂow across the nanopore can overcome the
electrostatic energy barrier opposing peptide capture. However,
the dwell times were faster and the Iex% lower than peptides with
similar mass (Table 1, Fig. 4b), suggesting that electrophoretic
and electrostatic interactions between the pore and the peptides
might prevent them from entering the sensing region of the
nanopore.
Thus, we tested a range of pHs where the aspartate and
glutamate side chains are expected to be protonated (Fig. 5a,
Table 1). We found that only at pH 3.8, the signal corresponding
to c-Myc 410–419 (1203.3 Da) fell between the signal of
angiotensin I (1296.5 Da), and angiotensin II (1046.2 Da, Fig. 5a),
suggesting that after losing its negative charges, c-Myc 410–419
peptide might access the recognition volume of FraC. Reward-
ingly, at pH 3.8 all the remaining peptides showed Iex% values that
scaled with the masses of the peptides (Fig. 5b). Notably, at
pH 3.8 the peptide signals showed relatively high variability
and the conditions had to be carefully controlled (Supplementary
Note 3). Most likely, this is because at pH 3.8 the charge
density of the constriction (Fig. 1a) is strongly affected by small
variations in pH.
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Fig. 3 Discrimination of peptides differing by a single amino acid using type
II W116S-fragaceatoxin C (FraC) at pH 4.5. a Peptide sequences of
angiotensin II, and A with typical blockades provoked by the two
angiotensin peptides measured at −30mV applied bias. b, c Color density
plot of the Iex% versus the standard deviation of the current amplitude for
angiotensin II, and A, respectively. d Separation of angiotensin II and A in a
mixture. Peptides were added into the cis chamber and measured under
−30mV. Standard deviations were calculated from at least three
independent repeats
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Peptide translocation across nanopores. It has been assumed43–46
and experimentally47 proven that the voltage dependence of the
average dwell time (τoff) can report on the translocation of a
molecule across a nanopore. Under a negative bias (trans) for
positively charged peptides (added in cis), both electrophoretic and
electroosmotic forces (from cis to trans) promote the entry and
translocation35 across the nanopore (Supplementary Figure 13). For
negatively charged peptides, such as c-Myc 410–419 at pH 4.5
(Fig. 5a), the electroosmotic driving force must be stronger than the
opposing electrophoretic force. The voltage dependence of τoff was
then examined for the most acidic peptide c-Myc 410–419 at dif-
ferent pH values (Fig. 5c). At pH 4.5, the peptide exhibited a
maximum in τoff at –50mV, suggesting that at low potentials c-Myc
410–419 returns to the cis chamber (<50mV), and at higher
potentials (>50mV) c-Myc 410–419 exits to the trans chamber. At
pH 3.8 and lower, we observed a decrease in τoff, albeit at higher
potentials, indicating that at pH 3.8 c-Myc 410–419 crossed the
membrane region of FraC to the trans chamber.
Discussion
We have engineered the assembly of FraC to obtain three
nanopores types with 1.6, 1.1, and 0.84 nm inner diameters. The
nanopores can accommodate peptides ranging from 22 to 4
amino acids in length. Smaller peptides might be detected using
further ﬁne tuning of the transmembrane region of the nanopore,
for example, by introducing amino acids with bulky side chains in
the recognition volume of the nanopore. We also showed that the
nanopores can discriminate differences between an alanine and a
glutamate (44 Da) in a mixture of peptides. Furthermore, we
found that at exactly pH 3.8 the ionic signal of the peptides
depended on the mass of the analyte, whereas at higher pH values
the current signal of negatively charged peptides was higher than
expected from their mass alone. Most likely, a negatively charged
recognition region is important for creating an electrostatic
environment for peptide mass recognition. At the same time, the
electrostatic interaction of the constriction with negatively
charged analytes might prevent the correct positioning of the
analyte within the reading frame of the nanopore. Hence, the
next-generation nanopores might be fabricated using unnatural
amino acids that hold a negative charge at a low pH range (e.g.,
sulfate or phosphate groups). Alternatively, peptides might be
chemically modiﬁed (e.g., by esteriﬁcation) to neutralize the
negative charge.
Mass spectrometry is the workhorse of the proteomics ﬁeld. At
present, the nanopore system falls short from the resolution of
commercial mass spectrometers. However, the technology is
young and improvements are to be expected. It should also be
noticed that a peptide mass analyzer device based on nanopores
will have distinctive advantages compared with conventional
mass spectrometers, the latter being expensive, extremely com-
plex, and unwieldy. By contrast, nanopores can be integrated in
portable and low-cost devices containing hundreds of thousands
of individual sensors. In addition, the electrical nature of the
signal allows sampling biological samples in real-time. Further-
more, since the nanopore reads individual molecules, the signal
contains additional information not available for ensemble
techniques. Finally, single-molecule detection, especially when
coupled to high-throughput analysis, is amenable for detecting
low abundance peptides and to unravel the chemical hetero-
geneity in PTMs, challenges that are hard to address with con-
ventional mass spectrometry.
A nanopore peptide mass detector might also be integrated in
real-time protein sequencing system, providing a number of
requirements are met. First, a protease-unfoldase pair should be
coupled directly above the nanopore sensor. The barrel-shaped
ATP-dependent ClpXP protease appears to be an ideal candidate
because it would encase the digested peptides preventing its
Table. 1 Peptide analysis with different types of FraC nanopores at pH 4.5




Charge Iex% pH 4.5 Dwell time
(ms)
pH 4.5 pH 3.8
Wt-FraC type I pore, –30mV
Endothelin 2 CSCSSWLDKECVYFCHLDIIW 2546.9 3.087 0.36 1.56 93.9 ± 1.8 104.0 ± 29.9
Endothelin 1 CSCSSLMDKECVYFCHLDIIW 2491.9 3.020 0.36 1.56 92.5 ± 0.5 19.73 ± 1.95
Dynorphin A YGGFLRRIRPKLKWDNQ 2147.5 2.599 4.48 4.97 84.9 ± 2.6 3.68 ± 0.76
Pre-angiotensinogen 1–14 DRVYIHPFHLVIHN 1758.9 2.130 3.45 3.96 75.4 ± 2.3 0.29 ± 0.04
Angiotensin I DRVYIHPFHL 1296.5 1.568 2.46 2.96 56.6 ± 0.9 0.15 ± 0.04
W116S-FraC type II pore, –30mV
Angiotensin I DRVYIHPFHL 1296.5 1.568 2.46 2.96 91.2 ± 0.2 0.54 ± 0.01
c-Myc 410-419 EQKLISEEDL 1203.3 1.456 −1.19 0.36 70.0 ± 3.4 0.12 ± 0.01
Angiotensin 1–9 DRVYIHPFH 1183.3 1.431 2.46 2.96 86.0 ± 0.2 0.37 ± 0.04
NLP-3 (66–75) YFDSLAGQSL 1099.2 1.331 −0.52 0.97 75.3 ± 3.0 0.23 ± 0.02
Angiotensin II DRVYIHPF 1046.2 1.266 1.47 1.96 82.1 ± 1.3 0.37 ± 0.04
Asn1Val5 AngioII NRVYVHPF 1031.2 1.248 2.03 2.16 80.4 ± 0.2 0.34 ± 0.06
Angiotensin A ARVYIHPF 1002.2 1.212 2.03 2.16 79.0 ± 0.6 0.34 ± 0.02
Angiotensin III RVYIHPF 931.1 1.127 2.03 2.16 77.9 ± 0.5 0.35 ± 0.04
Ile7 Angiotensin III RVYIHPI 897.1 1.085 2.03 2.16 75.7 ± 0.4 0.19 ± 0.05
Angiotensin IV VYIHPF 774.9 0.938 1.02 1.16 61.1 ± 4.0 0.15 ± 0.06
W112S-W116S-FraC type III pore, –50mV
Angiotensin IV VYIHPF 774.9 0.938 1.02 1.16 98.9 ± 0.8 0.61 ± 0.07
Angiotensin 4–8 YIHPF 675.8 0.818 1.02 1.16 91.8 ± 0.4 0.40 ± 0.04
Endomorphin I YPWF 610.7 0.741 0.04 0.17 80.3 ± 0.5 0.32 ± 0.04
Met5 Enkephalin YGGFM 573.7 0.695 0.04 0.17 66.5 ± 0.7 0.16 ± 0.02
Leucine Enkephalin YGGFL 555.6 0.673 0.04 0.17 65.6 ± 2.4 0.20 ± 0.05
The charges of the peptides were calculated according to the pKa for individual amino acid53. Standard deviations were obtained for at least three measurements
FraC fragaceatoxin C, Wt-FraC wild-type FraC
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release in solution. The coupling could be achieved by chemical
attachment, by genetic fusion, or by introducing binding loops to
the nanopore that interact with the peptidase. We have taken the
latter approach to couple α-hemolysin nanopores with hepta-
meric GroEL48. The cleaved peptides will be sequentially recog-
nized and translocated across the nanopore. Here we have taken
several steps showing this approach might be feasible. We
demonstrated that the peptides entering the cis side of the
nanopore have a high probability of exiting the nanopore to the
trans chamber, which will prevent duplicate detection events.
Furthermore, we showed that at pH 3.8 peptides are likely to be
captured and their mass recognized by the nanopore at a ﬁxed
applied potential irrespectively of their chemical composition. If
such low pH values will not be compatible with enzymatic
activity, asymmetric solutions on both side of the nanopore can
be used49–51. In such system, conditions in the cis side will be
tuned to optimize the ATPase activity of the unfoldase-peptidase,
whereas the pH and ionic strength of the trans side will be
optimized to capture and recognize individual peptides.
Methods
Chemicals. Endothelin 1 (≥97%, CAS# 117399-94-7), endothelin 2 (≥97%, CAS#
123562-20-9), dynorphin A porcine (≥95%, CAS# 80448-90-4), angiotensin I
(≥90%, CAS# 70937-97-2), angiotensin II (≥93%, CAS# 4474-91-3), c-Myc 410-419
(≥97%, # M2435), Asn1-Val5-Angiotensin II (≥97%, CAS# 20071-00-5), Ile7
Angiotensin III (≥95%, #A0911), leucine enkephalin (≥95%, #L9133), 5-
methionine enkephalin (≥95%, CAS# 82362-17-2), endomorphin I (≥95%, CAS#
189388-22-5), pentane (≥99%, CAS# 109-66-0), hexadecane (99%, CAS# 544-
76-3), Trizma®hydrochloride (≥99%, CAS# 1185-53-1), Trizma®base (≥99%, CAS#
77-86-1), potassium chloride (≥99%, CAS# 7447-40-7), N,N-
dimethyldodecylamine N-oxide (LADO, ≥99%, CAS# 1643-20-5) were obtained
from Sigma-Aldrich. Pre-angiotensinogen 1–14 (≥97%, # 002-45), angiotensin 1–9
(≥95%, # 002-02), angiotensin A (≥95%, # 002-36), angiotensin III (≥95%, # 002-
31), angiotensin IV (≥95%, # 002-28) NLP-3 (66–75) (≥97%, # 076-36) were
purchased from Phoenix Pharmaceuticals. Angiotensin 4–8 (≥95%) was synthe-
sized by BIOMATIK. 1,2-Diphytanoyl-sn-glycero-3-phosphocholine (DPhPC,
#850356P) and sphingomyelin (Porcine brain, # 860062) were purchased from
Avanti Polar Lipids. Citric acid (99.6%, CAS# 77-92-9) was obtained from ACROS.
n-Dodecyl β-D-maltoside (DDM, ≥99.5%, CAS# 69227-93-6) was bought from
Glycon Biochemical EmbH. DNA primers were synthesized from Integrated DNA
Technologies (IDT), enzymes from Thermo Scientiﬁc. All peptides were dissolved
with Milli-Q water without further puriﬁcation and stored in −20 °C freezer. pH
7.5 buffer containing 15 mM Tris in this study was prepared by dissolving 1.902 g
Trizma® HCl and 0.354 g Trizma® base in 1 liter Milli-Q water (Millipore, Inc.).
FraC monomer expression and puriﬁcation. FraC gene containing NcoI and
HindIII restriction sites at the 5ʹ and 3ʹ ends, respectively, and a sequence encoding
for a poly-histidine tag at the 3ʹ terminus was cloned into a pT7-SC1 plasmid.
Plasmids were transformed into BL21(DE3) E.cloni® competent cell by electro-
poration. Cells were grown on lysogeny broth (LB) agar plate containing 100 µ/mL
ampicillin overnight at 37 °C. The entire plate was then harvested and inoculated
into 200 mL fresh 2YT media and the culture was grown with 220 rpm shaking at
37 °C until the optical density at 600 nm of the cell culture reached 0.8. Then,
0.5 mM isopropyl β-D-thiogalactoside (IPTG) was added to the media and the
culture was transferred to 25 °C for overnight growth with 220 rpm shaking. The
next day, the cells were centrifuged (2000×g, 30 min) and the pellet stored at
−80 °C. FraC was puriﬁed from cell pellets harvested from 100 mL culture media.
In all, 30 mL of cell lysis buffer (150 mM NaCl, 15 mM Tris, 1 mM MgCl2, 4 M
urea, 0.2 mg/mL lysozyme, and 0.05 unit/mL DNase) were added to re-suspend the
pellet and vigorously mixed for 1 h. Cell lysate was then sonicated with Branson
Soniﬁer 450 for 2 min (duty cycle 10%, output control 3). Afterwards, the crude
lysate was centrifuged down at 4 °C for 30 min (5400 × g), and the supernatant
incubated with 100 µL Ni-NTA beads (Qiagen) for 1 h with gentle shaking. Beads
were spun down and loaded to a Micro Bio-spin column (Bio-Rad). In total, 10 mL
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Fig. 4 Recognition of peptides with different chemical composition at pH 4.5. On the top graph is the relation between the molecular weight (M.W.) or
volume of the peptide and the Iex%. The bottom ﬁgure shows the sensing volume of type I wild-type fragaceatoxin C (Wt-FraC) (a), type II W116S-FraC
(b), and type III W112S-W116S-FraC (c) nanopores. The solid line represents a second order polynomial ﬁtting in a, b and a linear ﬁtting in c, with the
extrapolated value at 100% Iex% corresponding to the volume of a peptide that would completely occupy the sensing volume of the nanopore. The latter is
most likely constricted to the volume included between the constriction of the pore (aspartic acid 10) and the residues that lie one turn of a helix above the
constriction (aspartic acid 17). The distances are measured from two opposing residues and include the van der Waals radii of the atoms. Current
blockades were measured at −30mV for type I and II pore, and at −50mV for type III pore in 1M KCl solutions. The error bars represent standard
deviation from at least three repeats. Red circles highlight the two peptides that bare a negative charge at pH 4.5 (Table 1)
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of SDEX buffer (150 mM NaCl, 15 mM Tris, pH 7.5) containing 20 mM imidazole
was used to wash the beads, and proteins were eluded with 150 µL elution buffer
(SDEX buffer, 300 mM imidazole). The concentration of the protein was deter-
mined by the absorption at 280 nm with Nano-drop 2000 (Thermo Scientiﬁc)
using the elution buffer as blank. To further conﬁrm the purity of monomer, the
protein solution was diluted to 0.5 mg/mL using the elution buffer and 9 µL of the
diluted sample was mixted with 3 µL of 4× loading buffer (250 mM Tris HCl, pH
6.8. 8% SDS, 0.01% bromophenol blue and 40% glycerol) and then loaded to 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Gels were
run under a constant applied current of 35 mA for 30 min, and stained with
Coomassie dye (InstantBlueTM, Expdedeon) before viewing using a gel imager (Gel
DocTM, Bio-Rad).
FraC mutation preparation. FraC mutants were prepared according to MEGA-
WHOP method54. In all, 25 µL REDTaq® ReadyMix™ was mixed with 4 µM primer
(Supplementary Figure 2) containing the desired mutation with 50 ng plasmid
(pT7-SC1 with Wt-FraC gene) as template and the ﬁnal volume was brought to
50 µL with Milli-Q water. The PCR protocol was initiated by a 150-s denature step
at 95 °C, followed by 30 cycles of denaturing (95 °C, 15 s), annealing (55 °C, 15 s),
and extension (72 °C, 60 s). The PCR products (MEGA primer) were combined
and puriﬁed using a QIAquick PCR puriﬁcation kit with a ﬁnal DNA concentra-
tion around 200 ng/µL. Then, a second PCR was performed using the MEGA
primer for whole-plasmid ampliﬁcation. In all, 2 µL of MEGA primer, 1 µL Phire II
enzyme, 10 µL 5× Phire buffer, 1 µL 10 mM dNTPs, were mixed with PCR water to
50 µL ﬁnal volume. PCR started with pre-incubated at 98 °C (30 s) and then 25
cycles of denaturing (98 °C, 5 s), extension (72 °C, 180 s). When the PCR was
completed, 1 µL DpnI enzyme was added and the mixture kept at 37 °C for 1 h.
Then, the temperature was raised to 65 °C for 1 min to inactivate the enzyme.
Products were then transformed into E. cloni® 10G cells (Lucigen) competent cell
by electroporation. Cells were grown on LB agar plates containing 100 µg/mL
ampicillin and were grown overnight at 37 °C. Single clones were enriched and sent
for sequencing.
Sphingomyelin-DPhPC liposome preparation. In all, 20 mg sphingomyelin and
20 mg DPhPC (1,2-diphytanoyl-sn-glycero-3-phosphocholine) were dissolved in
4 mL pentane with 0.5% v/v ethanol and brought to a round ﬂask. The solvent was
then removed by rotation while being heated using a hair dryer. After evaporation,
the ﬂask was kept at ambient temperature for an additional 30 min. The lipid ﬁlm
was resuspended with 4 mL SDEX buffer (150 mM NaCl, 15 mM Tris, pH 7.5) and
the solution immersed in a sonication bath for 5 min. Liposome suspensions were
stored at −20 °C.
FraC oligomerization. FraC oligomerization was triggered by incubation of FraC
monomers with sphingomyelin-DPhPC liposomes. Frozen liposome were thawed
and sonicated in a water bath for 1 min. FraC monomers were diluted to 1 mg/mL
using SDEX buffer, and then 50 µL of FraC monomers were added to 50 µl of a
10 mg/mL liposome solution to obtain a mass ratio of 10:1 (liposome:protein). The
lipoprotein solution was incubated at 37 °C for 30 min to allow oligomerization.
Then, 10 µl of 5% (w/v, 0.5% ﬁnal) N,N-Dimethyldodecylamine N-oxide (LDAO)
was added to the lipoprotein solution to solubilize the liposomes. After clariﬁcation
(typically 1 min), the solution was transferred to a 50 mL Falcon tube. Then, 10 mL
of SDEX buffer containing 0.02% DDM and 100 µL of pre-washed Ni-NTA beads
were added to the Falcon tube and mixed gently in a shaker for 1 h at room
temperature. The beads were then spun down and loaded to a Micro Bio-spin
column. In all, 10 mL wash buffer (150 mM NaCl, 15 mM Tris, 20 mM imidazole,
0.02% DDM, pH 7.5) was used to wash the beads and oligomers eluded with 100 µL
elution buffer (typically 200 mM EDTA, 75 mM NaCl, 7.5 mM Tris pH 7.5, 0.02%
DDM). The FraC oligomers were stored at 4 °C and the nanopores are stable for
several months.
W112S-W116S-FraC oligomer separation with His-Trap chromatography. In
total, 200 µL of W112S-W116S-FraC monomers (3 mg/mL) were incubated with
300 µL of Sphingomyelin-DPhPC liposome (10 mg/mL) and kept at 4 °C for 48 h
after which 0.5% LADO (ﬁnal concentration) was added to solubilize the lipo-
protein. Then the buffer was exchanged to 500 mM NaCl, 15 mM Tris, 0.01%
DDM, 30 mM imidazole, pH 7.5 (binding buffer) using a PD SpinTrap G-25
column. W112S-W116S-FraC oligomers were then loaded to Histrap HP 1 mL
column (General Electric) using an ÄKTA pure FPLC system (General Electric).
The loaded oligomers were washed with 10 column volumes of 500 mM NaCl,
15 mM Tris, 0.01% DDM, 30 mM imidazole, pH 7.5, prior to applying an imida-
zole gradient (from 30mM to 1M imidazole, 500 mM NaCl, 15 mM Tris, 0.01%
DDM, pH 7.5) over 30 column volumes. The protein concentration in ﬂow was
monitored with the absorbance at 280 nm and fractions were collected when the
absorbance was higher than 5 mAu.
Electrophysiology measurement and data analysis. Electrical recordings were
performed using two silver/silver-chloride electrodes immerged into an electro-
physiology chamber connected to an Axopatch 200B ampliﬁer (Axon Instrument).
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Fig. 5 A nanopore peptide mass identiﬁer. a Top, sequence of the four
peptides tested. The amino acids that have a positive charge are in blue
and the acidic residues in red. Below, pH dependence of the Iex% for
the four peptides (cis) using type II W116S-fragaceatoxin C (FraC)
nanopores under –30 mV applied potential. b Relationship between the
Iex% and the mass of peptides at pH 3.8. c Voltage dependence of c-Myc
dwell times at different pHs. All electrophysiology measurements were
carried out in 1 M KCl, 0.1 M citric acid. The charges of the peptides
were calculated according to the pKa for individual amino acids53.
Standard deviations were calculated from at least three independent
repeats
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polytetraﬂuoroethylene Teﬂon aperture (Goodfellow Cambridge Limited). The
aperture was pretreated with ~ 5 µL of hexadecane (10% v/v hexadecane in pen-
tane) before loading the buffer. A bilayer was formed using 10 µL of 10 mg/mL
DPhPC solution (in pentane), which was added into each compartment35,55. Ionic
currents were digitized with a Digidata 1440 A/D converter (Axon Instrument). All
peptides measurements were conducted with a 50 kHz sampling rate and a 10 kHz
Bessel ﬁlter. Single-channel events were collected by applying the single-channel
search function in Clampﬁt (Molecular Devices). Events shorter than 100 µs were
ignored. IO values, referring to open pore current, were measured by using
Gaussian ﬁttings to event amplitude histograms. Percent of excluded current values
(Iex%) were calculated by dividing the excluded current (IO – IB) by open pore
current (IO) and multiplied by 100. Dwell times and interevent times were mea-
sured by ﬁtting single exponentials to histograms of cumulative distribution.
Electrical recordings at pH 7.5 were performed using 1M NaCl solutions and
15 mM Tris, recordings at pH 4.5 were performed using 1 M KCl solutions in 0.1 M
citric acid and 180 mM Tris base.
Ion permeability measurement. In order to measure reversal potentials, a single
channel was obtained under symmetric conditions (840 mM KCl, 500 µL in each
electrophysiology chamber) and the electrodes were balanced. The 400 µL of a
buffered stock solution of 3.36 M KCl was then slowly added to cis chamber,
whereas 400 µL of salt-free buffered solution was added to the trans chamber to
obtain a total volume of 900 µL in both sides (trans:cis, 467 mM KCl:1960 mM
KCl). After the equilibrium was reached, IV curves were collected from −30
to +30 mV. The resulting voltage at zero current is the reversal potential (Vr). The
ion selectivity (PK+/PCl−) was then calculated using the Goldman–Hodgkin–Katz
equation52, Eq. (1), where ½aKþ=Cl cis=trans is the activity of the K+ or Cl− in the cis




¼ aCl½ trans aCl½ cise
VrF=RT
aKþ½ transeVrF=RT  aKþ½ cis
ð1Þ
The activity of ions was calculated by multiplying the molar concentration of
the ion with the mean ion activity coefﬁcients (0.649 for 500 mM KCl, and 0.573
for 2000 mM)56. Ag/AgCl electrodes were surrounded by 2.5% agarose bridges
containing a 2.5 M NaCl solution.
Molecular models of type I, II, and III FraC nanopores. The three-dimensional
models with different multimeric order, ranging from ﬁve to nine monomers, were
constructed with the symmetrical docking function of Rosetta57. A monomer
without lipids was extracted from the crystal structure of FraC with lipids (PDB_ID
4tsy33). Symmetrical docking arranged this monomer around a central rotational
axis ranging in order from 5 to 9. In total, Rosetta generated and scored 10,000
copies for each symmetry. In all cases, a multimeric organization with a symmetry
similar to the crystal structure could be identiﬁed as a top scoring solution.
However, in the pentameric assembly, the multimer interface was not fully satisﬁed
as compared with the crystal structure, with large portions left exposed. The
ninefold symmetric model, however, exhibited a signiﬁcant drop in Rosetta score
compared with the six-, seven-, and eightfold symmetric models indicating an
unfavored assembly of the nonameric assembly with the six-, seven-, and eightfold
assemblies as the most plausible. To create lipid-bound models, the crystal struc-
ture with lipids was superimposed on each monomer of the generated models,
allowing the lipid coordinates to be transferred. The residues within 4.5 angstrom
of the lipids were minimized with the Amber10 force ﬁeld.
Data availability
The authors declare that the data supporting the ﬁndings of this study are available
within the article and its supplementary information ﬁles or from the corresponding
authors upon reasonable request.
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